课题基金 / 基金详情

CHEMICAL RESEARCH IN THE DEVELOPMENT OF NEW ANTICANCER DRUGS

CHEMICAL RESEARCH IN THE DEVELOPMENT OF NEW ANTICANCER DRUGS
新型抗癌药物开发的化学研究
批准号：
3963199
负责人：
J S DRISCOLL
金额：
$0.0万
依托单位：
DIVISION OF CANCER TREATMENT
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3963199
关键词：
NAD(H) analog acetamides antiviral agents azacitidine aziridines cell differentiation chemical structure function cytidine cytosine arabinoside diazepine drug adverse effect drug design /synthesis /production drug metabolism drug screening /evaluation gas chromatography high performance liquid chromatography hydantoins myelogenous leukemia neoplasm /cancer pharmacology nitrogen mustard nucleoside analog phosphonate pyrimidine analog

项目摘要

项目成果

J S DRISCOLL的其他基金

相关文献

中文摘要
翻译
合成了许多HMBA类似物，并对其进行了区分评价
英文摘要
A number of HMBA analogs were synthesized and evaluated as differentiating agents in the in vitro HL-60 cell system. Several compounds were as effective and potent as HMBA but none were clearly superior.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHEMICAL RESEARCH IN THE DEVELOPMENT OF NEW ANTICANCER DRUGS
  • 批准号：
    4692071
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    J S DRISCOLL
  • 依托单位：
    DIVISION OF CANCER TREATMENT
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
  • 批准号：
    3939502
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    J S DRISCOLL
  • 依托单位：
    DIVISION OF CANCER TREATMENT
CNS TARGETED ANTIHIV AGENTS
FLUORONUCLEOSIDES AS CNS TARGETED ANTIHIV AGENTS